RCBC BidCo Pty Ltd Extends Offer to Acquire Parnell Pharmaceuticals Holdings Ltd

Parnell Acquires Noble Pharma

April 11, 2026

Pharmaceuticals

Parnell, a veterinary pharmaceutical company, announced it acquired Noble Pharma, a U.S.-based pharmaceutical manufacturer, under a Securities Purchase Agreement dated November 26, 2025. The deal adds an FDA- and DEA-accredited manufacturing facility to expand Parnell’s U.S. manufacturing footprint and improve supply continuity for its animal health products.

DW Healthcare Partners Invests in Parnell Pharmaceuticals

February 1, 2021

Veterinary

DW Healthcare Partners completed an investment in Parnell Pharmaceuticals Holdings Ltd, a fully integrated animal-health pharmaceutical developer and sterile-injectable manufacturer, and took seats on the company's board. DWHP said the capital and board expansion will support Parnell's growth in the U.S. and expansion of its product portfolio and manufacturing capabilities in animal health.

Torrent Pharmaceuticals Acquires Controlling Stake in J. B. Chemicals & Pharmaceuticals from KKR

June 29, 2025

Pharmaceuticals

Torrent Pharmaceuticals has agreed to acquire a controlling stake in J. B. Chemicals & Pharmaceuticals from KKR at an equity valuation of INR 25,689 crore, purchasing a 46.39% stake (with potential to aggregate to 49.19%) followed by a mandatory open offer and a planned merger. The deal strengthens Torrent's presence in the Indian pharmaceutical market and adds JB Pharma's CDMO and international capabilities to Torrent's platform.

Parabellum Investments Acquires Advanco

April 16, 2020

Pharmaceuticals

Parabellum Investments, an international private equity firm, has acquired Brussels-based pharma serialization specialist Advanco. Parabellum plans to scale Advanco's ARC serialization software internationally (initial focus: US, Russia and Europe) and pursue further acquisitions to grow the business in the pharmaceuticals market.

PI Industries Acquires Plant Health Care Plc

November 24, 2025

Agriculture

In August 2024 PI Industries Ltd. acquired Plant Health Care Plc (PHC) and has integrated the business into its global agriculture arm, PI AgSciences. The acquisition expands PI's biologicals and sustainable crop solutions capabilities and brings PHC subsidiaries across the U.S., Brazil, Mexico and other markets into PI's global platform.

Astellas Pharma to Acquire Propella Therapeutics

November 15, 2023

Biotechnology

Astellas Pharma, through a US subsidiary, has entered into a merger agreement to acquire Propella Therapeutics for approximately $175 million in cash. Propella is developing PRL-02 (abiraterone decanoate), a next-generation long-acting prodrug targeting prostate cancer, which is currently in Phase 1 with plans to enter Phase 2a in 2024.